Table 1 Baseline patient, angiographic and procedural characteristics according to diabetes status
Variable | No diabetes (n = 834) | Diabetes (n = 371) | P value |
|---|---|---|---|
Age (years) | 60 (51–68) | 60 (53–68) | 0.811 |
Male | 675 (80.9) | 280 (75.5) | 0.031 |
Current smoker | 467 (56.0) | 183 (49.3) | 0.032 |
Hypertension | 495 (59.4) | 242 (65.2) | 0.053 |
Dyslipidemia | 480 (57.6) | 230 (62.0) | 0.148 |
Previous myocardial infarction | 39 (4.7) | 26 (7.0) | 0.098 |
Previous PCI | 42 (5.0) | 28 (7.5) | 0.085 |
Previous stroke | 74 (8.9) | 44 (11.9) | 0.107 |
Peripheral vascular disease | 20 (2.4) | 16 (4.3) | 0.072 |
CKD in treatment | 16 (1.9) | 10 (2.7) | 0.392 |
OSAHS | 14 (1.7) | 2 (0.5) | 0.171 |
Heart rate (beats/min) | 76 (68–85) | 78 (70–85) | 0.101 |
Systolic blood pressure (mmHg) | 120 (108–130) | 120 (110–130) | 0.236 |
Laboratory data | |||
 Peak troponin (μg/L) | 68 (28–102) | 73 (28–102) | 0.808 |
 Peak CK (U/L) | 2101 (1124–3404) | 1977 (987–3347) | 0.204 |
 Peak CK-MB (U/L) | 227 (120–305) | 173 (85–299) | < 0.001 |
Time from symptom onset to PCI (h) | 5.0 (3.0–7.0) | 5.0 (3.5–8.0) | 0.009 |
Killip class III/IV | 74 (8.9) | 46 (12.4) | 0.059 |
Radial artery access | 295 (35.4) | 151 (40.7) | 0.077 |
No. narrowed coronary arteries | 0.778 | ||
 Two | 580 (69.5) | 255 (68.7) |  |
 Three | 254 (30.5) | 116 (31.3) |  |
Culprit vessel | 0.832 | ||
 Left anterior descending | 325 (39.0) | 138 (37.2) |  |
 Left circumflex | 112 (13.4) | 50 (13.5) |  |
 Right | 397 (47.6) | 183 (49.3) |  |
Non-culprit artery | |||
 Left anterior descending | 370 (44.4) | 178 (48.0) | 0.245 |
 Left circumflex | 453 (54.3) | 197 (53.1) | 0.696 |
 Right | 266 (31.9) | 111 (29.9) | 0.495 |
Thrombus aspiration | 582 (69.8) | 234 (63.1) | 0.021 |
No-reflow phenomenon | 80 (9.6) | 37 (10.0) | 0.837 |
Intra-aortic balloon pump use | 83 (10.0) | 36 (9.7) | 0.894 |
Glycoprotein IIb/IIIa inhibitor use | 224 (26.9) | 91 (24.5) | 0.395 |
Temporary pacemaker | 20 (2.4) | 15 (4.0) | 0.116 |
Defibrillator | 43 (5.2) | 18 (4.9) | 0.824 |
Drug-eluting stent use | 809 (97.0) | 360 (97.0) | 0.975 |
Type of stent | 0.276 | ||
 1st drug-eluting stent | 634 (76.0) | 265 (71.4) |  |
 2nd drug-eluting stent | 175 (21.0) | 95 (25.6) |  |
 Bare-mental stent | 2 (0.2) | 2 (0.5) |  |
 PTCA | 23 (2.8) | 9 (2.4) |  |
Stent number | 1 (1–2) | 1 (1–2) | 0.137 |
Total stent length (mm) | 33 (24–48) | 30 (24–42) | 0.080 |
Minimum stent diameter (mm) | 3.00 (2.50–3.50) | 3.00 (2.50–3.50) | 0.338 |
Medications at discharge | |||
 Aspirin | 833 (99.9) | 371 (100.0) | 1.000 |
 P2Y12 receptor inhibitor | 834 (100.0) | 371 (100.0) | 1.000 |
 ACEI/ARB | 617 (74.0) | 269 (72.5) | 0.592 |
 β-blockers | 693 (83.1) | 331 (89.2) | 0.006 |
 Statins | 826 (99.0) | 370 (99.7) | 0.289 |
Acute kidney injurya | 177 (21.3) | 74 (21.0) | 0.602 |